Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA
- PMID: 14580347
- DOI: 10.1016/s1097-2765(03)00388-5
Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA
Abstract
The positive transcriptional elongation factor b (P-TEFb), consisting of CDK9 and cyclin T, stimulates transcription by phosphorylating RNA polymerase II. It becomes inactivated when associated with the abundant 7SK snRNA. Here, we show that the 7SK binding alone was not sufficient to inhibit P-TEFb. P-TEFb was inhibited by the HEXIM1 protein in a process that specifically required 7SK for mediating the HEXIM1:P-TEFb interaction. This allowed HEXIM1 to inhibit transcription both in vivo and in vitro. P-TEFb dissociated from HEXIM1 and 7SK in cells undergoing stress response, increasing the level of active P-TEFb for stress-induced transcription. P-TEFb was the predominant HEXIM1-associated protein factor, and thus likely to be the principal target of inhibition coordinated by HEXIM1 and 7SK. Since HEXIM1 expression is induced in cells treated with hexamethylene bisacetamide, a potent inducer of cell differentiation, targeting the general transcription factor P-TEFb by HEXIM1/7SK may contribute to the global control of cell growth and differentiation.
Similar articles
-
Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding.Mol Cell Biol. 2006 Jan;26(2):630-42. doi: 10.1128/MCB.26.2.630-642.2006. Mol Cell Biol. 2006. PMID: 16382153 Free PMC article.
-
Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA.J Biol Chem. 2004 Feb 6;279(6):4153-60. doi: 10.1074/jbc.M310044200. Epub 2003 Nov 19. J Biol Chem. 2004. PMID: 14627702
-
A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.Mol Cell Biol. 2004 Jun;24(12):5094-105. doi: 10.1128/MCB.24.12.5094-5105.2004. Mol Cell Biol. 2004. PMID: 15169877 Free PMC article.
-
P-TEFb: The master regulator of transcription elongation.Mol Cell. 2023 Feb 2;83(3):393-403. doi: 10.1016/j.molcel.2022.12.006. Epub 2023 Jan 3. Mol Cell. 2023. PMID: 36599353 Free PMC article. Review.
-
7SK RNA, a non-coding RNA regulating P-TEFb, a general transcription factor.RNA Biol. 2009 Apr-Jun;6(2):122-8. doi: 10.4161/rna.6.2.8115. Epub 2009 Apr 6. RNA Biol. 2009. PMID: 19246988 Review.
Cited by
-
Dynamic regulation of P-TEFb by 7SK snRNP is integral to the DNA damage response to regulate chemotherapy sensitivity.iScience. 2022 Aug 4;25(9):104844. doi: 10.1016/j.isci.2022.104844. eCollection 2022 Sep 16. iScience. 2022. PMID: 36034227 Free PMC article.
-
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.Front Oncol. 2021 May 10;11:678559. doi: 10.3389/fonc.2021.678559. eCollection 2021. Front Oncol. 2021. PMID: 34041038 Free PMC article. Review.
-
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.Sci Adv. 2020 Aug 12;6(33):eaba6617. doi: 10.1126/sciadv.aba6617. eCollection 2020 Aug. Sci Adv. 2020. PMID: 32851167 Free PMC article.
-
Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes.PLoS Pathog. 2013;9(5):e1003338. doi: 10.1371/journal.ppat.1003338. Epub 2013 May 2. PLoS Pathog. 2013. PMID: 23658523 Free PMC article. Clinical Trial.
-
The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb.Sci Rep. 2016 Apr 12;6:24100. doi: 10.1038/srep24100. Sci Rep. 2016. PMID: 27067814 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous